TVMR With the INNOVALVE System Trial - Early Feasibility Study

NARecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2031

Conditions
Mitral Valve Regurgitation (Degenerative or Functional)
Interventions
DEVICE

INNOVALVE system

INNOVALVE system

Trial Locations (12)

10021

WITHDRAWN

Cornell, New York

10032

RECRUITING

NewYork-Presbyterian / Columbia University, New York

19104

RECRUITING

University of Pennsylvania, Philadelphia

30309

RECRUITING

Piedmont Heart Institute, Atlanta

37203

RECRUITING

Vanderbilt University Medical Center, Nashville

43214

RECRUITING

OhioHealth Research Institute, Columbus

44195

RECRUITING

Cleveland Clinic, Cleveland

48109

RECRUITING

University of Michigan Hospital and Health Systems, Ann Arbor

90048

RECRUITING

Cedars-Sinai, Los Angeles

97239

RECRUITING

Oregon Health & Science Universtiy, Portland

98122

RECRUITING

Swedish Medical Center, Seattle

555905

RECRUITING

Mayo Clinic, Rochester

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY